(Press-News.org) Bottom Line: A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due to immune-related adverse events (irAEs) continued to experience long-term disease control.
Journal in Which the Study was Published: Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR)
Authors: Senior author Mark Awad, MD, PhD, chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center, and first author Federica Pecci, MD, a research fellow at Dana-Farber Cancer Institute
Background: Immune checkpoint inhibitors have revolutionized the treatment landscape for NSCLC, offering significant survival benefits in both early-stage and advanced disease. However, by stimulating the immune system, ICIs can cause irAEs, such as pneumonitis, colitis, and hepatitis, which can also lead to permanent treatment discontinuation.
“When immunotherapy activates the immune system, the goal is to selectively target cancer cells. But this activation can also cause inflammation in other organs,” Awad said. “Whenever we see these side effects, we question whether we should keep giving immunotherapy or if we need to stop treatment temporarily or permanently.”
Between 3% and 12% of patients treated with a single ICI and up to 25% of patients treated with dual ICI combination therapy may need to discontinue treatment due to irAEs, Awad explained. Many of these patients face concerns about whether their cancer will progress or recur if they stop treatment.
How the Study was Conducted: Awad and colleagues sought to characterize the outcomes of patients with NSCLC who discontinued ICIs. They also evaluated clinical and pathological characteristics that were associated with longer PFS and OS after discontinuation.
Results: In a multi-institutional cohort of 2,794 patients who were treated with ICIs alone or in combination with other therapies, approximately 10% discontinued treatment due to irAEs; among these patients, the median post-discontinuation progression-free survival (PFS) was 12.7 months, and the median post-discontinuation overall survival (OS) was 43.7 months.
“These outcomes suggest that patients can experience prolonged disease control and survival after stopping treatment due to toxicity or if side effects are impacting their quality of life,” Pecci said.
Among patients who received treatment before discontinuing for less than three months, between three and six months, and more than six months, the median PFS after discontinuation was 6.2 months, 13.9 months, and 25.8 months, respectively; the median OS after discontinuation was 21.7 months, 42.7 months, and 86.9 months, respectively.
In a multivariable analysis, predictors of longer post-discontinuation PFS included high PD-L1 expression, a complete or partial response (CR/PR) to treatment, and a treatment duration of either three to six months or more than six months before discontinuation. Furthermore, factors associated with prolonged post-discontinuation OS were nonsquamous histology, CR/PR to treatment, and a treatment duration exceeding six months.
The use of steroids or other immunosuppressants to treat irAEs was not associated with a difference in PFS or OS after discontinuation in the study, suggesting that such treatments may not jeopardize the anticancer response.
Author’s Comments: “We identified clinical and pathological features that can help physicians to better understand which patients can benefit longer without any additional treatment after discontinuing for toxicity,” Pecci said. “Our study can serve as a valuable resource to support clinicians in the complex considerations of treatment discontinuation for irAEs.”
While discontinuation is clearly warranted in cases of severe irAEs, the management of grade 2 irAEs often presents a more nuanced challenge for clinicians. These findings may help physicians provide patients with a clearer, more individualized assessment of their risk of disease progression, Pecci said, taking into account factors such as treatment duration before discontinuation, response to therapy, and other clinicopathologic characteristics.
Study Limitations: Limitations of this study include its retrospective design, which could be hindered by missing or inaccurate data annotations. Additionally, comparisons based on treatment duration before discontinuation may be confounded by an overrepresentation of long-term responders in the longer-duration groups. To mitigate this, landmark analyses and multivariable Cox regression models were used to help reduce potential biases and enhance the reliability of the findings.
Funding & Disclosures: Funding for this study was provided by the National Institutes of Health. Awad has served as a consultant for Merck, Bristol Myers Squibb, Genentech, AstraZeneca, Blueprint Medicines, Synthekine, AbbVie, Gritstone bio, Mirati Therapeutics, Regeneron, Affini-T Therapeutics, and EMD Serono and has received institutional funding from Bristol Myers Squibb, Eli Lilly and Company, Genentech, AstraZeneca, and Amgen. Pecci reports no conflicts of interest.
END
Some patients may experience durable disease control even after discontinuing immune checkpoint inhibitors for side effects
2025-04-18
ELSE PRESS RELEASES FROM THIS DATE:
Native American names extend the earthquake history of northeastern North America
2025-04-18
In 1638, an earthquake in what is now New Hampshire had Plymouth, Massachusetts colonists stumbling from the strong shaking and water sloshing out of the pots used by Native Americans to cook a midday meal along the St. Lawrence River, according to contemporaneous reports.
When Roger Williams, founder of the Rhode Island colony, talked with local Native Americans, he reported that the younger tribe members were surprised by the earthquake. But older tribe members said they had felt similar shaking four times in the past 80 years.
In his talk at the Seismological ...
Lake deposits reveal directional shaking during devastating 1976 Guatemala earthquake
2025-04-18
Sediment cores drawn from four lakes in Guatemala record the distinct direction that ground shaking traveled during a 1976 magnitude 7.5 earthquake that devastated the country, according to researchers at the Seismological Society of America’s Annual Meeting.
The earthquake, which killed more than 23,000 people and left about 1.5 million people homeless, took place along the Motagua Fault, at the boundary between the North American and Caribbean tectonic plate boundary.
Severe ground shaking from the 1976 earthquake caused landslides ...
How wide are faults?
2025-04-18
At the Seismological Society of America’s Annual Meeting, researchers posed a seemingly simple question: how wide are faults?
Using data compiled from single earthquakes across the world, Christie Rowe of the Nevada Seismological Laboratory at the University of Nevada, Reno and Alex Hatem of the U.S. Geological Survey sought a more comprehensive answer, one that considers both surface and deep traces of seismic rupture and creep.
By compiling observations of recent earthquakes, Rowe and Hatem conclude that from Turkey to California, it’s not just a ...
Key enzyme in lipid metabolism linked to immune system aging
2025-04-17
Our immune systems weaken as we get older, making fewer cells that fight infection and help us recover from illness and injury. Scientists aren’t completely sure why. They may have a better idea now, however, thanks to a new study in GeroScience.
“Immune cell changes occur during aging for a number of reasons, but we still don’t completely understand why we have fewer antibody-producing cells with age,” said Leslie Crews, Ph.D., assistant professor of medicine at University of California San Diego School of Medicine, co-leader of the Hematologic Malignancies Research ...
Improved smoking cessation support needed for surgery patients across Europe
2025-04-17
Smokers and people who recently quit are more likely to face complications after having an operation than non-smokers, a new study reveals.
Experts say there is an urgent need for focussed action to encourage people to stop smoking before undergoing elective surgery, after the pan-European research revealed that 19.5% of elective surgery patients are current smokers.
Backed by National Institute for Health and Care Research (NIHR) funding, researchers discovered higher smoking rates among younger patients (18-40 years: 26.8%) and male patients (22.1%). Healthy adults without long-term conditions also exhibited ...
Study finds women much more likely to be aware of and have good understanding of obesity drugs
2025-04-17
*Note – this is an early press release from the European Congress on Obesity in Malaga, Spain, 11-14 May. Please credit the congress when using this research.*
New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that women are much more aware of knowledgeable about the obesity drugs GLP-1/GIP receptor agonists (that include semaglutide and tirzepatide). The study is by Nadja Auerbach, Voy*, London, UK and Dr Austen El-Osta, Director of the Self-Care Academic Research Unit (SCARU) at the School of Public Health, Imperial College London, UK, and colleagues.
Multiple ...
Study details role of protein that may play a key role in the development of schizophrenia
2025-04-17
Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and stability of myelin, suggesting an important impact on neurodegenerative diseases and mental disorders such as multiple sclerosis and schizophrenia. The findings pave the way for new research and potential treatments.
Myelin is a fatty substance produced by oligodendrocytes (cells of the central nervous system) that forms a sheath, like a kind of “insulator.” It “protects” the extensions of neurons (axons) and increases the conduction speed of nerve impulses that carry information ...
Americans don’t think bird flu is a threat, study suggests
2025-04-17
New York, NY | April 17, 2025 - In an editorial in the American Journal of Public Health, a team led by researchers from the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) say public ignorance and apathy towards bird flu (highly pathogenic avian influenza, or HPAI) could pose a serious obstacle to containing the virus and preventing a larger-scale public health crisis.
The authors, including CUNY SPH Assistant Professor Rachael Piltch-Loeb, Associate Professor Katarzyna Wyka, ...
New CDC report shows increase in autism in 2022 with notable shifts in race, ethnicity, and sex
2025-04-17
Researchers at the Johns Hopkins Bloomberg School of Public Health contributed to a new Centers for Disease Control and Prevention report examining autism among children who turned 4 and 8 years old in 2022. The CDC report, which includes data from 16 study sites across the U.S. including Maryland, found an overall prevalence of autism of 1 in 31 (3.2%) among 8-year-olds in 2022.
The Maryland study site, led by researchers at Bloomberg School’s Wendy Klag Center for Autism and Developmental Disabilities, found a prevalence of 1 in 38 (2.6%) ...
Modulating the brain’s immune system may curb damage in Alzheimer’s
2025-04-17
New research suggests that calming the brain’s immune cells might prevent or lessen the damaging inflammation seen in Alzheimer’s disease. The study points to the key role of the hormone and neurotransmitter norepinephrine, and this new understanding could pave the way for more focused treatments that start earlier and are tailored to the needs of each person.
“Norepinephrine is a major signaling factor in the brain and affects almost every cell type. In the context of neurodegenerative diseases such as Alzheimer’s disease, it ...